↓ Skip to main content

Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors

Overview of attention for article published in Investigational New Drugs, September 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent
3 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
40 Mendeley
citeulike
1 CiteULike